BioNano Genomics Inc (NASDAQ: BNGO) stock has been on a roll for quite some time and has managed to record gains of as much as 40% over the course of the past week.
One of the major reasons behind the latest rally in the stock is due to the fact that the company announced earlier this week that it has managed to regain compliance with regards to the NASDAQ minimum bid price requirement of its stock. The company received a letter from the exchange to that effect.
However, it is also important to point out that the Bionano stock has in fact delivered gains of as much as 1000% over the course of the past month alone. That could be linked to the fact that on January 11, the company announced that the possible applications of its optical genome mapping system known as Saphyr was discussed at the Next-Generation Cytogenomics Symposium. Considering these developments, it could be a good idea for investors to keep an eye on the Bionano stock.